Mutational signatures of non‐homologous and polymerase theta‐mediated end‐joining in embryonic stem cells
Joost Schimmel(Leiden University Medical Center), Marcel Tijsterman(Leiden University), Robin van Schendel(Leiden University Medical Center), Hanneke Kool(Leiden University Medical Center)
Cited by 156
Related Papers
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
|Nature Communications|2021|358
Site-Specific Identification of SUMO-2 Targets in Cells Reveals an Inverted SUMOylation Motif and a Hydrophobic Cluster SUMOylation Motif
|Molecular Cell|2010|310
In Vivo Identification of Human Small Ubiquitin-like Modifier Polymerization Sites by High Accuracy Mass Spectrometry and an in Vitro to in Vivo Strategy
|Molecular & Cellular Proteomics|2007|302
Uncovering SUMOylation Dynamics during Cell-Cycle Progression Reveals FoxM1 as a Key Mitotic SUMO Target Protein
|Molecular Cell|2014|178
The Ubiquitin-Proteasome System Is a Key Component of the SUMO-2/3 Cycle
|Molecular & Cellular Proteomics|2008|154